Kathleen Addison is an Executive Director and has been with the Life Sciences banking team for four years. She brings over 25 years of experience in commercial banking to find innovative solutions that assist small- to midcap life sciences companies. Combining her experience with J.P. Morgan’s well-respected healthcare industry expertise and access to key industry leaders, she can provide valued strategic discussion around the impact of R&D, milestones, positive date, the road to commercialization, financing for working capital and preparation for an exit. This enables her to cover each firm’s needs through its life cycle. Kathleen is based in New Jersey.
You're now leaving J.P. Morgan
J.P. Morgan’s website and/or mobile terms, privacy and security policies don’t apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan isn’t responsible for (and doesn’t provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan name.